Skip to Main Content

Paper Details

The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Nat Med
146
2020
ASCproject, Angiosarcoma, Angiosarcoma of the head, neck, face and scalp, HNFS, KDR, PIK3CA, TP53, adult, angiosarcoma, anti-PD, breast angiosarcoma, germline specimens, patient, patients, programmed death-1 protein, rare cancer, rare cancers, rare diseases, recurrently mutated genes, sarcoma, tumor, tumors, tumors1
Author NameAffiliation
Jason L HornickBrigham and Women's Hospital, Harvard Medical School
Yen-Lin ChenMassachusetts General Hospital
Eric S Lander
Eric S LanderHarvard Medical School
Eric S LanderMassachusetts Institute of Technology
Eric S LanderThe Broad Institute of MIT and Harvard
Eric S Lander
Eric S LanderThe Broad Institute of MIT and Harvard
Eric S LanderMassachusetts Institute of Technology
Eric S LanderHarvard Medical School
Todd R Golub
Todd R GolubDana-Farber Cancer Institute, Harvard Medical School
Todd R GolubThe Broad Institute of MIT and Harvard
Todd R Golub
Todd R GolubThe Broad Institute of MIT and Harvard
Todd R GolubDana-Farber Cancer Institute, Harvard Medical School
Nikhil Wagle
Nikhil WagleThe Broad Institute of MIT and Harvard
Nikhil WagleDana-Farber Cancer Institute, Harvard Medical School
Nikhil WagleCenter for Cancer Genomics, Dana-Farber Cancer Institute, Harvard Medical School
Nikhil WagleBrigham and Women's Hospital, Harvard Medical School
Nikhil Wagle
Nikhil WagleThe Broad Institute of MIT and Harvard
Nikhil WagleDana-Farber Cancer Institute, Harvard Medical School
Nikhil WagleCenter for Cancer Genomics, Dana-Farber Cancer Institute, Harvard Medical School
Nikhil WagleBrigham and Women's Hospital, Harvard Medical School
  • 1 - 26

Datasets